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Study objectives: To ascertain if equations that calculate continuous likelihood
ratios (CLRs) for pleural exudates improve pleural fluid categorization, especially
when false positive or false negative test results are obtained by using Light’s
criteria.
Design and setting: Retrospective review of the clinical and pleural fluid data from
a consecutive series of patients with pleural effusion who underwent thoracentesis
at the University Hospital Arnau de Vilanova (Lleida, Spain) over an 11-year period.
Patients and methods: A total of 1490 patients with pleural effusion (298
transudates and 1192 exudates) were recruited into the study. The presence of a
transudate or exudate was established by clinical judgment. We examined the
comparative diagnostic accuracy of 4 tests (i.e. pleural fluid protein and lactate
dehydrogenase (LDH), and pleural fluid to serum protein and LDH ratios) for
discriminating between transudates and exudates. Decision thresholds were
determined by receiver operating characteristics (ROC) analysis. Equations for
calculating CLRs derived from a logistic regression analysis based on a previously
described method.
Results: Individual pleural fluid tests did not differ in their diagnostic accuracies
according to ROC analysis. We calculated CLRs for the elements of Light’s criteria
and pleural fluid protein, and also illustrated the sequential use of CLRs for
determining posttest probabilities. Overall, CLR formulas had marginal performance
for the correct categorization of pleural fluid.Elsevier Ltd. All rights reserved.
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is a transudate or exudate. However, clinical judgment is little changed by the
application of CLRs, and in doubtful cases a great amount of uncertainty remains.
This Bayesian approach is likely to have no major impact on the clinical practice.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Determining the transudative or the exudative
nature of pleural fluid represents the first step in
the work up of pleural effusions of unknown
etiology. In clinical practice, an exudate is diag-
nosed if one or more of the following criteria are
meet (Light’s criteria)1: (1) pleural fluid protein to
serum protein ratio greater than 0.5, (2) pleural
fluid lactate dehydrogenase (LDH) to serum LDH
ratio greater than 0.6, (3) pleural fluid LDH greater
than two-thirds the upper limit of normal for serum
LDH. The ‘‘or’’ statement of Light’s criteria results
in maximal sensitivity, but reduces specificity. In
fact, some patients with pleural effusion due to
heart failure fulfill the criteria for an exudate. This
most commonly occurs when the patient is taking
diuretics. It has been recommended that serum-
effusion protein or albumin gradients can be used
as a more specific confirmatory test for patients
that have a condition usually associated with a
transudate (e.g. heart failure) but have an exuda-
tive result by Light’s criteria.2 Heffner et al.
addressed a new approach to overcome the
misclassification problem of Light’s criteria, namely
the application of Bayesian strategies that makes
use of continuous likelihood ratios (CLR).3 This
intriguing concept suggests that a test alone does
not distinguish exudate from transudate; rather,
the test only influence the probability of being an
exudate or transudate. To date, data are limited to
the Heffner’s meta-analysis. In the present report,
we aimed to calculate CLRs for estimating the
probability of an exudative effusion in the largest
series from a single center to our knowledge. Our
hypothesis was that the application of CLRs would
not improve significantly the categorization of
those pleural effusions misclassified by standard
criteria.Patients and methods
Since January 1993 we have maintained a database
on all patients who undergo thoracentesis in the
Arnau de Vilanova University Hospital (Lleida,
Spain), which has also been used for othertransudate–exudate studies.4–10 A total of 1490
patients with pleural effusion for whom a final
diagnosis could be achieved entered the present
study. The following clinical data were abstracted:
age, sex, final diagnosis, serum protein and LDH
concentrations, and pleural fluid test results. The
study protocol was approved by the local ethics
committee.
The causes of pleural effusions were determined
by well-established clinical criteria.11 Specifically,
criteria for transudates required the exclusion of
any disease associated with an exudative effusion,
and 3 or more months of patient followup to
determine whether alternative diagnoses became
clinically apparent. Diagnosis of heart failure was
based on history, physical examination, chest
radiographs, electrocardiogram and/or echocardio-
gram, and response to diuretic therapy. Tubercu-
lous pleuritis was diagnosed if Ziehl–Neelsen stains
or Lo¨wenstein cultures of pleural fluid, sputum or
pleural biopsy tissue samples were positive, a
pleural biopsy showed granuloma in the parietal
pleura, or an exudative lymphocytic effusion with
high adenosine deaminase levels (440U/L) cleared
in response to antituberculous therapy. The pleural
effusion was said to be malignant if any of the
following findings were present: a positive pleural
fluid cytology, a positive pleural biopsy, or a known
malignancy without clinically apparent alternative
causes of pleural fluid formation. Hepatic hydro-
thorax was defined as an effusion secondary to
cirrhosis in the presence of ascites, whereas
parapneumonic effusions were those associated
with bacterial pneumonia.
All biochemical measurements in pleural fluid
and serum were performed on a selective discrete
multichannel analyzer (Hitachi 717 and 917; Hita-
chi, Tokyo, Japan) using standard methodology. In
our laboratory the upper normal limit for LDH in
serum is 470 U/L.Statistical analysis
We examined the discriminative properties of 4
pleural fluid tests: protein, LDH, pleural fluid to
serum protein ratio, and pleural fluid to serum LDH
ratio. Receiver operating characteristics (ROC)
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these tests. The point of the ROC curve intersected
by a line with a slope set at 0.5 according to theTable 1 Clinical characteristics of the patients.
Characteristics Data
Patients (no.) 1490
Mean age (yr) 61719
Men 890 (60)
Women 600 (40)
Transudates 298 (20)
Heart failure 220
Cirrhosis 48
Other 30
Exudates 1192 (80)
Malignancy 414
Pneumonia 293
Tuberculosisy 173
Miscellaneous 312
Data are presented as mean7SD or no. (%) unless
otherwise indicated. Transudates and exudates were
defined by clinical criteria (see text).
yThere were 69 patients with bacteriological confirmed
tuberculosis and 104 patients defined by adenosine
deaminase criteria.
Table 2 Comparison of pleural fluid data between trans
Variables n
Protein (g/dL) 1467
Pleural fluid to serum protein ratio 1271
LDH (UI/L) 1449
Pleural fluid to serum LDH ratio 1065
Data are presented as mean7SD. Transudates and exudates w
Table 3 Measures of diagnostic accuracy for pleural tes
Criteria Sensitivity (%) Specificity (%)
Protein 86.3 (84.3–88.3) 85.9 (82–89.9)
Pleural fluid to
serum protein ratio
92.9 (91.3–94.5) 79.1 (74.2–84)
LDH 91.8 (90.2–93.3) 80.5 (76–85)
Pleural fluid to
serum LDH ratio
89.5 (87.5–91.6) 88.5 (84.1–92.8)
Light’s criteriay
(n ¼ 1424)
97.5 (96.6–98.4) 80 (75.4–84.6)
95% CIs in parentheses. The positive likelihood ratio (LR+) is de
positive rate (1-specificity). The negative likelihood ratio (LR) i
by the specificity.
yFor the application of Light’s criteria, pleural LDH was set at 31
laboratory’s serum value).prevalence-cost equation served as the cutoff value
for identifying exudates, as previously reported.12
Sensitivities, specificities, likelihood ratios, and
area under ROC curves (AUC) with 95% CIs for all
of the individual tests were calculated.
The calculation of the CLRs equations of an
exudate for a given quantitative pleural fluid result
was based on the method of Simel and co-work-
ers.13 This method generates an equation for CLRs
in the form of exp[b(pleural fluid test–x0)]. Terms
within the equation are derived from logistic
regression models wherein the variable ‘‘pleural
fluid test’’ represents a discrete test value for
which a CLR to predict the occurrence of an
exudate is being calculated. The variable x0 is the
pleural fluid test result for which the log odds at
the prevalence of an exudate within the patient
registry equals a+bx0. It was calculated by the
following equation: x0 ¼ (ln[p0/(1p)0]–a)/b,
wherein p0 is the prevalence of exudates, and the
constants a and b are parameter estimates from the
logistic regression models. When using CLRs in
series only independent criteria were combined in
order to avoid overestimation of posttest probabil-
ities.
A two-tailed P value p0.05 was considered
significant. Data were analyzed by using theudates and exudates.
Transudates Exudates P
2.1570.94 4.3271.12 o0.0001
0.3470.14 0.6670.14 o0.0001
180793 195975460 o0.0001
0.4470.24 5.12719.64 0.001
ere defined by clinical criteria (see text).
ts that identify an exudates.
LR+ LR AUC (%)
6.12 (4.6–8.1) 0.16 (0.14–0.19) 92.5 (91–93.8)
4.5 (3.5–5.6) 0.09 (0.07–0.11) 94 (92.6–95.3)
4.7 (3.7–5.9) 0.10 (0.08–0.13) 94.1 (92.8–95.3)
6.5 (4.5-9.2) 0.11 (0.09–0.14) 94.6 (93–95.8)
4.8 (3.8-6.2) 0.03 (0.02–0.04)
fined as the true positive rate (sensitivity) divided by the false
s calculated by dividing the false negative rate (1-sensitivity)
2U/L (more than two-thirds the upper limits of normal for our
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Table 4 Results of the logistic regression model for each pleural fluid test criteria as explanatory variables for
predicting an exudate.
Variables p0 a b SE Wald w2 P x0
Protein 0.797 4.295 1.777 0.101 309.3 o0.0001 3.187
Pleural fluid to serum protein ratio 0.789 5.454 13.458 0.808 277.3 o0.0001 0.503
LDH 0.794 0.927 3.829 0.181 445.8 o0.0001 0.594
Pleural fluid to serum LDH ratio 0.805 3.395 6.585 0.545 146.2 o 0.0001 0.731
p0 ¼ prevalence of exudates in each subgroup; constants a and b ¼ parameter estimates from the logistic regression model;
SE ¼ standard error for b; x0 ¼ pleural fluid test result for which the log odds at the prevalence of an exudate within the patient
registry equals a+bx0.
LDH as a fraction of the upper limits of the laboratory normal value.
Table 5 Continuous likelihood ratios equations
for discrete pleural fluid test criteria results.
Pleural fluid test Equations
Protein exp [1.77 (result–3.187)]
Pleural fluid to
serum protein ratio
exp [13.46
(result–0.503)]
LDH exp [3.83 (result–0.594)]
Pleural fluid to
serum LDH ratio
exp [6.59 (result–0.731)]
Table 6 An example of the serial use of contin-
uous likelihood ratios (CLRs) to categorize a pleural
effusion as exudate or transudate.
Pleural fluid results
Pleural fluid to serum protein ratio ¼ 0.60
Pleural fluid LDH (fraction of laboratory
normal) ¼ 0.54
Calculation of posttest probability
Pretest probability of an exudate ¼ 20%
Serial CLRs for each pleural fluid test
exp [13.46 (0.60–0.503)] ¼ 3.69
exp [3.83 (0.54–0.594)] ¼ 0.81
Pretest odds ¼ pretest probability/(1-pretest
probability) ¼ 0.20/(1–0.20) ¼ 0.25
Pretest odds is multiplied by the continuous LRs
Bayesian methods in pleural effusion 1963SPSS statistical package (version 10.0; SPSS;
Chicago, IL).in series
0.25 3.69 ¼ 0.922
0.922 0.81 ¼ 0.74
Posttest probability of an exudate ¼ posttest odds/
(1+posttest odds) ¼ 0.74/(1+0.74) ¼ 43%
A 70-year-old woman with a history of aortic stenosis
was admitted for progressive dyspnea and orthopnea. She
was on diuretic therapy. Her physical examination was
notable for the presence elevated jugular venous pulse, a
holosystolic murmur and peripheral edema. Chest radio-
graphy showed an enlarged heart, blunting of the left
costophrenic angle and a large right-sided pleural effu-
sion. Because most of the clinical features suggested
heart failure, the physician assumed that the prior
probability of an exudate was only 20%. However, pleural
fluid obtained by thoracentesis was categorized as an
exudate by Light’s criteria. Posttest probability is
calculated by using continuous likelihood ratios. Pleural
effusion responded to management of heart failure.Results
Of the 1490 patients studied, 298 (20%) had
transudates and 1192 (80%) had exudates. The
specific diagnoses are listed in Table 1. As com-
pared with exudates, transudates had significantly
lower mean levels of all of the four pleural fluid
tests (Table 2). Cutoff points derived from the ROC
analysis that best discriminate exudative from
transudative effusions were as follows: protein
43.06 g/dL, pleural fluid to serum protein ratio
40.44, LDH447% of upper limits of normal of
serum (224 U/L), and pleural fluid to serum LDH
ratio 40.63. Comparative diagnostic accuracies of
individual pleural fluid tests using the established
cutoff points are shown in Table 3. Overlap of the
AUC confidence intervals indicated that no single
test could be clearly identified as being superior to
others. Light’s criteria had 97.5% sensitivity and
80% specificity in identifying pleural exudates.
Table 4 shows parameters estimates and signifi-
cant testing results from the logistic regression
analysis. Each pleural fluid test criterion wassignificantly associated with the response variable
of the presence or absence of an exudate (all
Po0:0001). The equations that compute a CLR for
estimating the probability of an exudate for each
measured pleural fluid test value are represented
in Table 5. Since pleural fluid to serum LDH and
pleural fluid LDH were highly correlated
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Table 7 Some examples of conversion of prior probabilities of an exudate into posterior probabilities with the
use of CLR equations.
Examples Estimated pretest probability
of an exudate (%)
Calculated posttest probability of an
exudate by applying
Current study’s
equations (%)
Heffner’s
equations (%)
Pleural fluid tests (classification by Light’s criteria)
PF/S protein ¼ 0.60 10 25 16.5
LDH PF ¼ 0.54 20 43 31
(exudate) 50 75 64
80 92 88
90 96 94
PF/S protein ¼ 0.67 10 32 19.5
LDH PF ¼ 0.39 20 52 35.5
(exudate)y 50 81 69
80 94.5 90
90 97.5 95
PF/S protein ¼ 0.45 10 3 2
LDH PF ¼ 0.45 20 6.5 4
(transudate)z 50 22 13
80 53 38
90 60 58
CLR ¼ continuous likelihood ratio.
Example from Table 6.
yA 87-year-old woman was evaluated because of dyspnea on exertion and at rest. Chest radiograph showed cardiomegaly and
a moderate right-sided pleural effusion, which cleared with diuretics. Final diagnosis was heart failure.
zA 60-year-old woman with a prior history of breast cancer and no cardiovascular risk factors presented with progressive
dyspnea. She had cardiac tamponade and a small bilateral pleural effusion. Malignant cells were identified in both pericardial
and pleural fluids. Diagnosis of metastatic breast cancer was made.
J.M. Porcel et al.1964(r ¼ 0:906), the former was omitted to apply CLRs
in series.
As a working example Table 6 illustrates the
application of CLRs to a patient with clinically
suspected heart failure whose pleural fluid met
standard criteria for an exudate. The physician
estimated the pretest probability of an exudate at
20%. The final posttest probability of an exudative
effusion increased to 43%, a result which still
favored a transudate yet required additional
diagnostic tests. In different clinical examples,
slightly higher posttest probabilities percentages
resulted from the application of our CLR equations
as compared with those reported by Heffner et al.
in their multicenter registry (Table 7).Discussion
Clinicians have increasingly come to appreciate the
virtues of Bayesian reasoning and to recognize the
importance of the ‘‘pretest probability’’ of a givencondition in interpreting the results of any diag-
nostic test. Recently, Heffner et al. used multi-
level14 and CLRs3 to calculate the probability of
having an exudate after a discrete pleural fluid test
result was obtained. To do so, a physician should
first estimate the prior probability of an exudative
effusion based on clinical grounds. The application
of the Bayesian strategy makes use of the fact that
the farther the results of a laboratory test is above
or below the cutoff level, the more likely the fluid
is exudative or transudative, respectively.
In the current paper, we have reproduced and
confirmed previous findings3 in a registry of
patients from a single center rather than in a
meta-analysis, thus eliminating the problems
brought about by quality of the primary studies.
Although our results compare with those of
Heffner et al.,3 we are in disagreement with their
optimistic interpretation on the benefits of the
Bayesian approach to pleural fluid categorization.
As shown in Table 7, CLR equations only marginally
improve classification of the pleural fluid when the
pretest probability of exudate or transudate is
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effusion is unclear, i.e. the pretest probability of
exudate or transudate is intermediate, a significant
insecurity as to the final categorization of fluid will
remain. CLRs are intended to circumvent the
misclassification that can occur when effusions
are dichotomized by Light’s criteria. Nevertheless,
very high levels or very low levels of any of the
standard tests used in separating exudates and
transudates indicate a very high likelihood of an
exudative or transudative effusion, respectively. In
other words, Bayesian reasoning is a formal way of
doing explicitly what most physicians do implicitly,
that is, interpreting the results of a diagnostic test
(e.g. standard criteria) in light of the clinical
situation. In this sense, a high or low clinical
suspicion should not be altered by borderline test
results.
A couple of additional drawbacks for the applica-
tion of CLRs merit consideration. Firstly, the
pretest probability of an exudate or transudate
results from the subjective physician judgment,
which is greatly influenced by the consistent
interpretation of clinical features. It has been our
experience that pretest probabilities vary markedly
between experienced clinicians. Secondly, CLRs
formulas should be programmed into computerized
decision support platforms or personal digital
assistants for bedside use.
To conclude, Bayesian method quantifies diag-
nostic confidence but does not much improve
accuracy regarding the correct categorization of
pleural fluid into exudate or transudate. The
familiarity, simplicity and accuracy of Light’s
criteria should be balanced against the adoption
of new and somewhat cumbersome strategies for
exudates–transudate categorization.References
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